Facilities

Fujifilm to produce COVID-19 vaccines, BARDA speeds up capacity boost

03-Aug-2020 By Ben Hargreaves

US BARDA drafts Fujifilm Diosynth into its vaccine production effort, offering to also accelerate capacity expansion.

The growth of the UK’s ‘golden triangle’

22-Jul-2020 By Ben Hargreaves

Research outlines the pace of growth in the UK’s biohub and how it will progress towards 2050.

Ireland calls attention to cell and gene infrastructure

22-Jul-2020 By Ben Hargreaves

A report by IDA outlines investment made by biopharma into cell and gene development and manufacturing capabilities.

MassBio wants improved manufacturing to maintain biohub position

22-Jul-2020 By Ben Hargreaves

The organization calls for capabilities to manufacture advanced therapeutics, such as cell and gene therapies.

Catalent to invest $30m on clinical manufacturing site in France

21-Jul-2020 By Ben Hargreaves

The company invests into its clinical biologics formulation development and drug fill-finish services.

Rentschler and Vetter cooperate to integrate services

09-Jul-2020 By Ben Hargreaves

The CDMOs will launch pilot projects to determine where collaboration may help streamline drug development.

Emergent signs $480m, five-year vaccine deal with J&J

07-Jul-2020 By Ben Hargreaves

Emergent will provide contract development and manufacturing services for J&J’s potential COVID-19 vaccine.

Regeneron COVID-19 antibody cocktail enters late-stage trials

07-Jul-2020 By Ben Hargreaves

Regeneron’s potential coronavirus treatment enters Phase III and US government provides capital injection for manufacture.

Moderna secures fill-finish capabilities for COVID-19 vaccine

29-Jun-2020 By Ben Hargreaves

Moderna signs deal with Catalent for fill-finish services, shortly after AZ announced the same move.

Cytiva expands Massachusetts biomanufacturing site

25-Jun-2020 By Ben Hargreaves

The facility has been expanded to cater to the growing number of small- to mid-size biotechs looking to contract manufacture.

Novo Nordisk provides €100m for sustainable cell factories

22-Jun-2020 By Ben Hargreaves

Novo Nordisk Foundation donates funds to DTU Biosustain to continue its work to develop methods for sustainable biotechnologies.

Emergent in $75m expansion into viral vectors and gene therapy

22-Jun-2020 By Ben Hargreaves

The company will buildout its Massachusetts facility to provide CDMO services for viral vector and gene therapies.

Sanofi to invest €610m in vaccine production site

18-Jun-2020 By Ben Hargreaves

The company will create both a vaccine site and an R&D center in France.

TreeFrog opens stem cell manufacturing facility

16-Jun-2020 By Ben Hargreaves

The startup completes work on facility to produce stem cell therapies in-house.

WuXi Biologics signs lease for US clinical-stage facility

16-Jun-2020 By Ben Hargreaves

The CDMO announces the lease of its third site in the US, the latest being focused on clinical supply.